151 related articles for article (PubMed ID: 23498161)
1. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
[TBL] [Abstract][Full Text] [Related]
2. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
[TBL] [Abstract][Full Text] [Related]
3. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
[TBL] [Abstract][Full Text] [Related]
4. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
Fedson SE; Daniel SS; Husain AN
J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
7. Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.
Xu Y; Galambos C; Reyes-Múgica M; Miller SA; Zeevi A; Webber SA; Feingold B
J Heart Lung Transplant; 2013 Jan; 32(1):92-7. PubMed ID: 23260709
[TBL] [Abstract][Full Text] [Related]
8. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
9. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
10. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.
Kfoury AG; Snow GL; Budge D; Alharethi RA; Stehlik J; Everitt MD; Miller DV; Drakos SG; Reid BB; Revelo MP; Gilbert EM; Selzman CH; Bader FM; Connelly JJ; Hammond ME
J Heart Lung Transplant; 2012 Jan; 31(1):46-51. PubMed ID: 22153551
[TBL] [Abstract][Full Text] [Related]
13. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
Mohamedali B; Pyle J; Bhat G
Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
[TBL] [Abstract][Full Text] [Related]
14. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
15. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
16. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
17. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
[TBL] [Abstract][Full Text] [Related]
18. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
[TBL] [Abstract][Full Text] [Related]
19. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
20. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S
Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
